{"title": "Handig die LCI-richtlijn van het RIVM", "author": null, "url": "https://lci.rivm.nl/richtlijnen/waterpokken-en-gordelroos", "hostname": "rivm.nl", "description": null, "sitename": "LCI richtlijnen", "date": "2014-09-23", "cleaned_text": "deze richtlijn incorrect is. Wel bestaat er een kans dat zeer Versiebeheer De richtlijn is vastgesteld 23 september 2014. Wijzigingen: - 14-04-2023: Aanpassingen gedaan op basis de bloed te isoleren of met PCR aan te meeste de pati\u00ebnt van het centraal zenuwstelsel. De kans op zonder dat er genotypes van het varicellazostervirus spelen mogelijk ook een rol in de re-infecties. Reservoir mens. Besmettingsweg De besmetting is ook mogelijk door direct (slijmvlies)contact met de inhoud van de blaasjes van een patient met waterpokken of bij foetus. Een re\u00eble arbitrair met waterpokken of - (< 2 meter) gedurende minste met name mensen kan ook huisartsconsulten bedraagt slechts enkele sterfgevallen door waterpokken: \u00e9\u00e9n in 2009, twee in \u00e9\u00e9n in 2013). huishouden met doorgemaakte waterpokken en met wie de zwangere ten tijde van de waterpokken in van 'strikte isolatie' tot 7 dagen na het begin van de huidafwijking (tot de af is geen zwangeren in het bijzonder te informeren of op bij gehad, zwangerschap, bij van een werk waterpokken binnen een van 7 dagen voor af Infectious Diseases. [Red Book](https://doi.org/10.1542/9781581109276). Elk Grove Village III; 2000. - American Academy of Pediatrics. Committee on Infectious Diseases. Varicella Vaccine Uptake. Pediatrics 2000;105:136-141. - Arvin AM, AE. Immunologic varicella-zoster virus. J Infect Dis 1983;148:200-205. - Asano Y et al. Viraemia is present in the incubation period in nonimmunocompromised children with varicella. J Paedlatr 1985;106:69?71. Asano S, Iwayama S, Miyata T, Yazaki T, Takahashi M. Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination. Biken J 1982;25:43-5. - Briggs, G. G., Freeman, R. K., & Yaffe, S. J. (2007). Drugs in pregnancy & lactation. (8th ed.) Wolters Kluwer, Lippincott. Williams & Wilkins. - Brisson 2002, Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox - CBS 2013 (link) - CDC Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP), mmwr 1996;45 (RR11):1-25. - CDC. Prevention of varicella updated recommendations of the Advisory Committee on Immunization Practices (ACIP), mmwr 1999;48 (RR06):1-5. - CDC. Surveillance for Vaccination Coverage Among Children and Adults - United States MMWR 2000;49:No. SS-9. - Centers for Disease Control Morb Mortal Wkly Rep 2007;56(October (41)):Q1-4. 2007;56 - Disease Control and Prevention. MMWR Morb Mortal Wkly Rep - Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol 1994;35:673-679. - Eckstein R, Jehn U, Loy A. Endemic chickenpox on a cancer ward. J. Infect. Dis 1984;149:829-830. - Enders G, Miller E, Cradock-Watson J et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548?51. - Farmacotherapeutisch Kompas (website 28 mei 2013) - Feldman S. Epp E. Detection of viraemia during incubation of varicella. J Paediatr 1979;94:746?748. - Goldman Review of the United States universal varicella vaccination program: Herpeszoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on [http://www.ncbi.nlm.nih.gov/pubmed/22659447](http://www.ncbi.nlm.nih.gov/pubmed/22659447)2013 - Griffith JF, Salam JV, Adams RD. The nervous system diseases associated with varicella. Acta Neurol Scand 1970;46:279-300. - Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, et al. Second varicella infections: are they more common than previously thought? Pediatrics. 2002;109(6):1068-1073. - Harger JH, Ernest JM, Thurnau GR et al. Risk factors and outcome of Varicella-Zoster virus pneumonia in pregnant women. JID 2002;185:422-7. - Harper DR, Gilbert LR, Jeffries DJ. UK Advisory Group on Chickenpox. Molecular Biology of varicella-zoster Virus. Journal of Infection 1998;36,Supplement 1:1-10. - Herman JA. Immunoassays for the diagnosis of infectious diseases. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual BP, Stehr-Green P, Ericson RL, Mason CJ. The susceptibility of young adult Americans to vaccine-preventable infections: a national serosurvey of US Army recruits. 266: 2724-2729. - Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I; Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine, [Pediatr Infect Dis J. 2004 Feb;23(2):132-7.](http://www.ncbi.nlm.nih.gov/pubmed/14872179) - Landry ML, Cohen SD, Mayo DR, Fong CKY, Andiman WA. Comparison of fluorescent-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for to varicella-zoster virus. Clin Microbiol 1987;25:832-5. - Lier, van A, van Hoek AJ, Opstelten W, Boot HJ, de Melker HE. Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. BMC Health Serv Res. 2010;10:237. - Lier, van A, van Smits G, Mollema L, Waaijenborg S, Berbers G, van der Klis F, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013;31(44):5127-33. - Lier, van EA, et al. Varicella zoster virus (VZV) infection. In: Melker, de H, et al. The National Immunisation Programme in the Netherlands: Developments in 2013. [RIVM Report 150202002/2013](http://www.rivm.nl/bibliotheek/rapporten/150202002.pdf); 92-99. - Lin and herpes zoster hopitalisations: the pre-varicella vaccine PV. outbreaks in Army recruits from Puerto Rico. 1990. Varicella susceptibility in a population from the tropics. - Maas, van der, NA, Bondt PE, de Acute cerebellar ataxia the Netherlands: study association with vaccinations and varicella zoster infection. [Vaccine 2009;27(13):1970-3](https://www.ncbi.nlm.nih.gov/pubmed/19186201). - Maple, P. A. C., Gray, J., Brown, K., & Brown, D. (2009). Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence antibody following natural infection. J.Virol.Methods, 157, 90-92. - McKinney WP, Horowitz MM, Bartiola RJ. Susceptibility op hospital-based health care personnel to varicella-zoster virus infections. Am J Infect Control 1989;17:26-30. - Melker, de H, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24(18):3946-52. - Melker, de H, et al. The National Immunisation Programme in the Netherlands: Developments in 2013. RIVM Report 150202002/2013. - Miller E, Cradock?Watson JE, Ridehalgh MK. Outcome in newborn babies given antivaricellazoster immunoglobulin after perinatal maternal infection with varicella?zoster virus. Lancet 1989;2:371?3. - Nathwani, D., Maclean, A., Conway, S., & Carrington, D. (1998). Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J.Infect., 36 Suppl 1, 59-71. - van Weert, RIVM publicatie 2012 - Remington, J. S. & Klein, J. O. (2006). Infectious Diseases of the Fetus and Newborn Infant. (6th ed.) Philadelphia: WB Saunders & Co. - Robert Koch Institut. AH. Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 1962; 276:369-376. - Saiman, L., Larussa, P., Steinberg, S. P., Zhou, J., Baron, K., Whittier, S. et al. (2001). Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect.Control Hosp.Epidemiol., 22, 279-283. - Schurink-van 't Klooster TM, de Melker HE. The National Immunisation Programme in the Netherlands - Surveillance and developments in 2015-2016. Bilthoven: Rijksinstituut voor PJ, Powles RL, Janeson B, Kay HE, Watson JG, Thornton R, et al. Parenteral aciclovir therapy for herpesvirus infections in man. Lancet 1979;2:1267-70. - Sinha DP. Chickenpox - a disease predominantly affecting adults in West Bengal, India. Int J Epidem 1976;5:367-374 - Smith, C. K. & Arvin, A. M. (2009). Varicella in the fetus and newborn. Semin.Fetal Neonatal Med., 14, 209-217. - Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90. - Terada K, Kawano S, Shimada Y, Yagi Y, Kataoka N. Recurrent chickenpox after natural infection. The Pediatric infectious disease journal. 1996;15(2):179-181. - Tischer A, F\u00e4rber Samengevat in Epidemiologisches Bulletin 2000;46:368-369. Robert Koch Institut. - Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, Levenson R. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105:84-8. - Weller TH, agents of varicella and herpes zoster: serologic studies with the viruses as propagated in vitro. J Exp Med 1958; 228:336-337. - Weller TH. Varicella-herpes zoster virus. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans. Epidemiology and control, 4th ed. Plenum N York, 1997;865-892 - Williams V, Gershon A, Brunell P. Serologic response to varicella zoster membrane Recommended Vaccines for Healthcare workers. [http://www.cdc.gov/vaccines/adults/recvac/hcw.html](http://www.cdc.gov/vaccines/adults/rec-vac/hcw.html) - CDC 2007. Isolation Precautions:Appendix A - HICPAC. [http://www.cdc.gov/hicpac/2007ip/2007ip_appenda.html](http://www.cdc.gov/hicpac/2007ip/2007ip_appenda.html) - CDC shingles (herpes zoster). [http://www.cdc.gov/shingles/hcp/HC-settings.html](http://www.cdc.gov/shingles/hcp/HC-settings.html) - Couturier A. Occupational and environmental Infectious diseases. Second edition. Beverly Farms: OEM Press, 2009 - FCB Dienstverlening in arbeidsmarktvraagstukken. Infectiepreventiekaarten. - National Institute of Health Promoting universal vaccination among workers. Health "}